{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:51:44Z","timestamp":1777067504564,"version":"3.51.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1038\/nrc1188","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T22:16:12Z","timestamp":1069712172000},"page":"745-755","source":"Crossref","is-referenced-by-count":554,"title":["Cannabinoids: potential anticancer agents"],"prefix":"10.1038","volume":"3","author":[{"given":"Manuel","family":"Guzm\u00e1n","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BFnrc1188_CR1","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni, Y. & Mechoulam, R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646\u20131647 (1964).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnrc1188_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett, A. C. et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161\u2013202 (2002). A comprehensive update on cannabinoid receptors and their biochemistry and pharmacology.","journal-title":"Pharmacol. Rev."},{"key":"BFnrc1188_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham, M. et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563\u2013583 (1991).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0163-7258(01)00130-9","volume":"90","author":"AC Porter","year":"2001","unstructured":"Porter, A. C. & Felder, C. C. The endocannabinoid nervous system. Unique opportunities for therapeutic intervention. Pharmacol. Ther. 90, 45\u201360 (2001).","journal-title":"Pharmacol. Ther."},{"key":"BFnrc1188_CR5","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1517\/13543784.9.7.1553","volume":"9","author":"RG Pertwee","year":"2000","unstructured":"Pertwee, R. G. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Expert Opin. Investig. Drugs 9, 1553\u20131571 (2000).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrc1188_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1517\/13543784.12.1.39","volume":"12","author":"G Di Carlo","year":"2003","unstructured":"Di Carlo, G. & Izzo, A. A. Cannabinoids for gastrointestinal diseases: potential therapeutic applications. Expert Opin. Investig. Drugs 12, 39\u201349 (2003).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrc1188_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00023210-200317030-00004","volume":"17","author":"JL Croxford","year":"2003","unstructured":"Croxford, J. L. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs 17, 179\u2013202 (2003).","journal-title":"CNS Drugs"},{"key":"BFnrc1188_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1192\/bjp.178.2.107","volume":"178","author":"P Robson","year":"2001","unstructured":"Robson, P. Therapeutic aspects of cannabis and cannabinoids. Br. J. Psychiatry 178, 107\u2013115 (2001).","journal-title":"Br. J. Psychiatry"},{"key":"BFnrc1188_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","volume":"323","author":"MR Tramer","year":"2001","unstructured":"Tramer, M. R. et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323, 16\u201321 (2001). A detailed review on the best palliative action of cannabinoids in cancer therapy that has been established so far.","journal-title":"BMJ"},{"key":"BFnrc1188_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00520-003-0530-0","volume":"11","author":"D Walsh","year":"2003","unstructured":"Walsh, D., Nelson, K. A. & Mahmoud, F. A. Established and potential therapeutic applications of cannabinoids in oncology. Support Care Cancer 11, 137\u2013143 (2003).","journal-title":"Support Care Cancer"},{"key":"BFnrc1188_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","volume":"137","author":"M Barann","year":"2002","unstructured":"Barann, M. et al. Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br. J. Pharmacol. 137, 589\u2013596 (2002).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrc1188_CR12","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrc927","volume":"2","author":"MJ Tisdale","year":"2002","unstructured":"Tisdale, M. J. Cachexia in cancer patients. Nature Rev. Cancer 2, 862\u2013871 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1188_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0163-7258(02)00257-7","volume":"95","author":"EM Berry","year":"2002","unstructured":"Berry, E. M. & Mechoulam, R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol. Ther. 95, 185\u2013190 (2002). An authoritative review on the physiological role and therapeutic potential of cannabinoids in appetite stimulation.","journal-title":"Pharmacol. Ther."},{"key":"BFnrc1188_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.ijo.0802250","volume":"27","author":"D Cota","year":"2003","unstructured":"Cota, D. et al. Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. Relat. Metab. Disord. 27, 289\u2013301 (2003).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"BFnrc1188_CR15","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002","volume":"22","author":"R Gomez","year":"2002","unstructured":"Gomez, R. et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22, 9612\u20139617 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1124\/mol.63.4.908","volume":"63","author":"M Bensaid","year":"2003","unstructured":"Bensaid, M. et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells. Mol. Pharmacol. 63, 908\u2013914 (2003).","journal-title":"Mol. Pharmacol."},{"key":"BFnrc1188_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1172\/JCI17725","volume":"112","author":"D Cota","year":"2003","unstructured":"Cota, D. et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 112, 423\u2013431 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrc1188_CR18","first-page":"14","volume":"10","author":"K Nelson","year":"1994","unstructured":"Nelson, K., Walsh, D., Deeter, P. & Sheehan, F. A phase II study of \u03b4-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. J. Palliat. Care 10, 14\u201318 (1994).","journal-title":"J. Palliat. Care"},{"key":"BFnrc1188_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","volume":"20","author":"A Jatoi","year":"2002","unstructured":"Jatoi, A. et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J. Clin. Oncol. 20, 567\u2013573 (2002).","journal-title":"J. Clin. Oncol."},{"key":"BFnrc1188_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh, P. W., Clohisy, D. R., Koltzenburg, M. & Hunt, S. P. Molecular mechanisms of cancer pain. Nature Rev. Cancer 2, 201\u2013209 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1188_CR21","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","volume":"63","author":"RG Pertwee","year":"2001","unstructured":"Pertwee, R. G. Cannabinoid receptors and pain. Prog. Neurobiol. 63, 569\u2013611 (2001).","journal-title":"Prog. Neurobiol."},{"key":"BFnrc1188_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0163-7258(02)00252-8","volume":"95","author":"J Walker","year":"2002","unstructured":"Walker, J. & Huang, S. Cannabinoid analgesia. Pharmacol. Ther. 95, 127\u2013135 (2002).","journal-title":"Pharmacol. Ther."},{"key":"BFnrc1188_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A Calignano","year":"1998","unstructured":"Calignano, A., LaRana, G., Giuffrida, A. & Piomelli, D. Control of pain initiation by endogenous cannabinoids. Nature 394, 277\u2013281 (1998).","journal-title":"Nature"},{"key":"BFnrc1188_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.323.7303.13","volume":"323","author":"FA Campbell","year":"2001","unstructured":"Campbell, F. A. et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323, 13\u201316 (2001). A lively discussion on the possible therapeutic value of cannabinoids as analgesic agents.","journal-title":"BMJ"},{"key":"BFnrc1188_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cpt197518184","volume":"18","author":"R Noyes Jr","year":"1975","unstructured":"Noyes, R. Jr, Brunk, S. F., Avery, D. A. H. & Canter, A. C. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin. Pharmacol. Ther. 18, 84\u201389 (1975).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnrc1188_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1471-4892(01)00120-5","volume":"2","author":"L Iversen","year":"2002","unstructured":"Iversen, L. & Chapman, V. Cannabinoids: a real prospect for pain relief. Curr. Opin. Pharmacol. 2, 50\u201355 (2002).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrc1188_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","volume":"20","author":"J Manzanares","year":"1999","unstructured":"Manzanares, J. et al. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20, 287\u2013294 (1999).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrc1188_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1517\/13543784.12.4.561","volume":"12","author":"D Baker","year":"2003","unstructured":"Baker, D. & Pryce, G. The therapeutic potential of cannabis in multiple sclerosis. Expert Opin. Investig. Drugs 12, 561\u2013567 (2003).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"BFnrc1188_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","volume":"55","author":"AE Munson","year":"1975","unstructured":"Munson, A. E., Harris, L. S., Friedman, M. A., Dewey, W. L. & Carchman, R. A. Antineoplastic activity of cannabinoids. J. Natl Cancer Inst. 55, 597\u2013602 (1975). The seminal demonstration that THC inhibits tumour-cell growth in culture and in mice.","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1188_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0163-7258(02)00256-5","volume":"95","author":"M Guzman","year":"2002","unstructured":"Guzman, M., Sanchez, C. & Galve-Roperh, I. Cannabinoids and cell fate. Pharmacol. Ther. 95, 175\u2013184 (2002).","journal-title":"Pharmacol. Ther."},{"key":"BFnrc1188_CR31","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1042\/bj3120637","volume":"312","author":"M Bouaboula","year":"1995","unstructured":"Bouaboula, M. et al. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1. Biochem. J. 312, 637\u2013641 (1995).","journal-title":"Biochem. J."},{"key":"BFnrc1188_CR32","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","volume":"237","author":"M Bouaboula","year":"1996","unstructured":"Bouaboula, M. et al. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237, 704\u2013711 (1996).","journal-title":"Eur. J. Biochem."},{"key":"BFnrc1188_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1042\/bj3460835","volume":"346","author":"J Liu","year":"2000","unstructured":"Liu, J. et al. Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem. J. 346, 835\u2013840 (2000).","journal-title":"Biochem. J."},{"key":"BFnrc1188_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1124\/mol.58.4.814","volume":"58","author":"D Rueda","year":"2000","unstructured":"Rueda, D., Galve-Roperh, I., Haro, A. & Guzman, M. The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol. Pharmacol. 58, 814\u2013820 (2000).","journal-title":"Mol. Pharmacol."},{"key":"BFnrc1188_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00333.x","volume":"77","author":"P Derkinderen","year":"2001","unstructured":"Derkinderen, P., Ledent, C., Parmentier, M. & Girault, J. A. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J. Neurochem. 77, 957\u2013960 (2001).","journal-title":"J. Neurochem."},{"key":"BFnrc1188_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37\u201340 (2001).","journal-title":"Nature"},{"key":"BFnrc1188_CR37","doi-asserted-by":"publisher","first-page":"46645","DOI":"10.1074\/jbc.M206590200","volume":"277","author":"D Rueda","year":"2002","unstructured":"Rueda, D., Navarro, B., Martinez-Serrano, A., Guzman, M. & Galve-Roperh, I. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1\/B-Raf\/ERK pathway. J. Biol. Chem. 277, 46645\u201346650 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1188_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/bj3470369","volume":"347","author":"T Gomez del Pulgar","year":"2000","unstructured":"Gomez del Pulgar, T., Velasco, G. & Guzman, M. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B\/Akt. Biochem. J. 347, 369\u2013373 (2000).","journal-title":"Biochem. J."},{"key":"BFnrc1188_CR39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0898-6568(03)00036-6","volume":"15","author":"MG Sanchez","year":"2003","unstructured":"Sanchez, M. G., Ruiz-Llorente, L., Sanchez, A. M. & Diaz-Laviada, I. Activation of phosphoinositide 3-kinase\/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell. Signal. 15, 851\u2013859 (2003).","journal-title":"Cell. Signal."},{"key":"BFnrc1188_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Rev. Cancer 2, 489\u2013501 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1188_CR41","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.4049\/jimmunol.170.10.4953","volume":"170","author":"MT Samson","year":"2003","unstructured":"Samson, M. T. et al. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J. Immunol. 170, 4953\u20134962 (2003).","journal-title":"J. Immunol."},{"key":"BFnrc1188_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/0264-6021:3630183","volume":"363","author":"T Gomez del Pulgar","year":"2002","unstructured":"Gomez del Pulgar, T., Velasco, G., Sanchez, C., Haro, A. & Guzman, M. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem. J. 363, 183\u2013188 (2002).","journal-title":"Biochem. J."},{"key":"BFnrc1188_CR43","doi-asserted-by":"publisher","first-page":"22330","DOI":"10.1074\/jbc.272.35.22330","volume":"272","author":"M Bouaboula","year":"1997","unstructured":"Bouaboula, M. et al. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor\/ligand interactions. J. Biol. Chem. 272, 22330\u201322339 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1188_CR44","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1124\/mol.62.6.1385","volume":"62","author":"I Galve-Roperh","year":"2002","unstructured":"Galve-Roperh, I., Rueda, D., Gomez Del Pulgar, T., Velasco, G. & Guzman, M. Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor. Mol. Pharmacol. 62, 1385\u20131392 (2002).","journal-title":"Mol. Pharmacol."},{"key":"BFnrc1188_CR45","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1523\/JNEUROSCI.23-06-02371.2003","volume":"23","author":"P Derkinderen","year":"2003","unstructured":"Derkinderen, P. et al. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23, 2371\u20132382 (2003).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR46","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1124\/mol.54.5.834","volume":"54","author":"C Sanchez","year":"1998","unstructured":"Sanchez, C., Galve-Roperh, I., Rueda, D. & Guzman, M. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the \u03949\u2013tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol. Pharmacol. 54, 834\u2013843 (1998).","journal-title":"Mol. Pharmacol."},{"key":"BFnrc1188_CR47","doi-asserted-by":"publisher","first-page":"25847","DOI":"10.1074\/jbc.R200008200","volume":"277","author":"YA Hannun","year":"2002","unstructured":"Hannun, Y. A. & Obeid, L. M. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277, 25847\u201325850 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1188_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI0216127","volume":"110","author":"R Kolesnick","year":"2002","unstructured":"Kolesnick, R. The therapeutic potential of modulating the ceramide\/sphingomyelin pathway. J. Clin. Invest. 110, 3\u20138 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrc1188_CR49","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1124\/mol.59.5.955","volume":"59","author":"C Sanchez","year":"2001","unstructured":"Sanchez, C. et al. The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol. Pharmacol. 59, 955\u2013959 (2001).","journal-title":"Mol. Pharmacol."},{"key":"BFnrc1188_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/73171","volume":"6","author":"I Galve-Roperh","year":"2000","unstructured":"Galve-Roperh, I. et al. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Med. 6, 313\u2013319 (2000). The first identification of a signalling mechanism for the apoptotic action of cannabinoids on tumour cells.","journal-title":"Nature Med."},{"key":"BFnrc1188_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0014-5793(98)01085-0","volume":"436","author":"C Sanchez","year":"1998","unstructured":"Sanchez, C., Galve-Roperh, I., Canova, C., Brachet, P. & Guzman, M. \u03949\u2013Tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436, 6\u201310 (1998).","journal-title":"FEBS Lett."},{"key":"BFnrc1188_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-6147(00)01586-8","volume":"22","author":"M Guzman","year":"2001","unstructured":"Guzman, M., Galve-Roperh, I. & Sanchez, C. Ceramide: a new second messenger of cannabinoid action. Trends Pharmacol. Sci. 22, 19\u201322 (2001).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrc1188_CR53","first-page":"5784","volume":"61","author":"C Sanchez","year":"2001","unstructured":"Sanchez, C. et al. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor. Cancer Res. 61, 5784\u20135789 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc1188_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pros.10190","volume":"56","author":"M Mimeault","year":"2003","unstructured":"Mimeault, M., Pommery, N., Wattez, N., Bailly, C. & Henichart, J. P. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate 56, 1\u201312 (2003).","journal-title":"Prostate"},{"key":"BFnrc1188_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0014-5793(00)01425-3","volume":"472","author":"KP Sarker","year":"2000","unstructured":"Sarker, K. P., Obara, S., Nakata, M., Kitajima, I. & Maruyama, I. Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett. 472, 39\u201344 (2000).","journal-title":"FEBS Lett."},{"key":"BFnrc1188_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1471-4159.2003.01663.x","volume":"85","author":"KP Sarker","year":"2003","unstructured":"Sarker, K. P. et al. ASK1-p38 MAPK\/JNK signaling cascade mediates anandamide-induced PC12 cell death. J. Neurochem. 85, 50\u201361 (2003).","journal-title":"J. Neurochem."},{"key":"BFnrc1188_CR57","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","volume":"95","author":"L De Petrocellis","year":"1998","unstructured":"De Petrocellis, L. et al. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl Acad. Sci. USA 95, 8375\u20138380 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc1188_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0014-5793(99)01639-7","volume":"463","author":"D Melck","year":"1999","unstructured":"Melck, D. et al. Involvement of the cAMP\/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett. 463, 235\u2013240 (1999).","journal-title":"FEBS Lett."},{"key":"BFnrc1188_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/endo.141.1.7239","volume":"141","author":"D Melck","year":"2000","unstructured":"Melck, D. et al. Suppression of nerve growth factor trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141, 118\u2013126 (2000).","journal-title":"Endocrinology"},{"key":"BFnrc1188_CR60","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1096\/fj.01-0320fje","volume":"15","author":"M Bifulco","year":"2001","unstructured":"Bifulco, M. et al. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J. 15, 2745\u20132747 (2001).","journal-title":"FASEB J."},{"key":"BFnrc1188_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI200316116","volume":"111","author":"ML Casanova","year":"2003","unstructured":"Casanova, M. L. et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J. Clin. Invest. 111, 43\u201350 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrc1188_CR62","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"R Kerbel","year":"2002","unstructured":"Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nature Rev. Cancer 2, 727\u2013739 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc1188_CR63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1096\/fj.02-0795fje","volume":"17","author":"C Blazquez","year":"2003","unstructured":"Blazquez, C. et al. Inhibition of tumor angiogenesis by cannabinoids. FASEB J. 17, 529\u2013531 (2003). The first paper showing that cannabinoid administration to mice impairs tumour angiogenesis.","journal-title":"FASEB J."},{"key":"BFnrc1188_CR64","doi-asserted-by":"crossref","unstructured":"Portella, G. et al. Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. FASEB J. 3 Jul 2003 (doi:10.1096\/fj.02-1129fje).","DOI":"10.1096\/fj.02-1129fje"},{"key":"BFnrc1188_CR65","doi-asserted-by":"publisher","first-page":"36527","DOI":"10.1074\/jbc.M205797200","volume":"277","author":"T Gomez Del Pulgar","year":"2002","unstructured":"Gomez Del Pulgar, T., De Ceballos, M. L., Guzman, M. & Velasco, G. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase\/protein kinase B pathway. J. Biol. Chem. 277, 36527\u201336533 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1188_CR66","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1523\/JNEUROSCI.22-22-09742.2002","volume":"22","author":"E Molina-Holgado","year":"2002","unstructured":"Molina-Holgado, E. et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase\/Akt signaling. J. Neurosci. 22, 9742\u20139753 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR67","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1096\/fj.00-0122com","volume":"14","author":"C Blazquez","year":"2000","unstructured":"Blazquez, C., Galve-Roperh, I. & Guzman, M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J. 14, 2315\u20132322 (2000).","journal-title":"FASEB J."},{"key":"BFnrc1188_CR68","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","volume":"17","author":"M Glass","year":"1997","unstructured":"Glass, M. & Felder, C. C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17, 5327\u20135333 (1997).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR69","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.1523\/JNEUROSCI.19-21-09271.1999","volume":"19","author":"C Vasquez","year":"1999","unstructured":"Vasquez, C. & Lewis, D. L. The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J. Neurosci. 19, 9271\u20139280 (1999).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR70","first-page":"162","volume":"57","author":"S Mukhopadhyay","year":"2000","unstructured":"Mukhopadhyay, S., McIntosh, H. H., Houston, D. B. & Howlett, A. C. The CB1 cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol. Pharmacol. 57, 162\u2013170 (2000).","journal-title":"Mol. Pharmacol."},{"key":"BFnrc1188_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","volume":"8","author":"R Mechoulam","year":"2002","unstructured":"Mechoulam, R., Panikashvili, D. & Shohami, E. Cannabinoids and brain injury: therapeutic implications. Trends Mol. Med. 8, 58\u201361 (2002).","journal-title":"Trends Mol. Med."},{"key":"BFnrc1188_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1385\/MN:26:2-3:317","volume":"26","author":"M van der Stelt","year":"2002","unstructured":"van der Stelt, M. et al. Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol. Neurobiol. 26, 317\u2013346 (2002).","journal-title":"Mol. Neurobiol."},{"key":"BFnrc1188_CR73","doi-asserted-by":"publisher","first-page":"31938","DOI":"10.1074\/jbc.M005722200","volume":"275","author":"M Maccarrone","year":"2000","unstructured":"Maccarrone, M., Lorenzon, T., Bari, M., Melino, G. & Finazzi-Agro, A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275, 31938\u201331945 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrc1188_CR74","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s001090000177","volume":"78","author":"M Guzman","year":"2001","unstructured":"Guzman, M., Sanchez, C. & Galve-Roperh, I. Control of the cell survival\/death decision by cannabinoids. J. Mol. Med. 78, 613\u2013625 (2001).","journal-title":"J. Mol. Med."},{"key":"BFnrc1188_CR75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0165-5728(94)90152-X","volume":"55","author":"H Schwarz","year":"1994","unstructured":"Schwarz, H., Blanco, F. J. & Lotz, M. Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J. Neuroimmunol. 55, 107\u2013115 (1994).","journal-title":"J. Neuroimmunol."},{"key":"BFnrc1188_CR76","first-page":"1103","volume":"286","author":"W Zhu","year":"1998","unstructured":"Zhu, W., Friedman, H. & Klein, T. W. \u03949-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J. Pharmacol. Exp. Ther. 286, 1103\u20131109 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrc1188_CR77","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","volume":"165","author":"LX Zhu","year":"2000","unstructured":"Zhu, L. X. et al. \u0394-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165, 373\u2013380 (2000).","journal-title":"J. Immunol."},{"key":"BFnrc1188_CR78","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0014-5793(95)00746-V","volume":"369","author":"JM Derocq","year":"1995","unstructured":"Derocq, J. M., Segui, M., Marchand, J., Le Fur, G. & Casellas, P. Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett. 369, 177\u2013182 (1995).","journal-title":"FEBS Lett."},{"key":"BFnrc1188_CR79","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood.V90.4.1448","volume":"90","author":"P Valk","year":"1997","unstructured":"Valk, P. et al. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells. Blood 90, 1448\u20131457 (1997).","journal-title":"Blood"},{"key":"BFnrc1188_CR80","doi-asserted-by":"publisher","first-page":"71S","DOI":"10.1002\/j.1552-4604.2002.tb06006.x","volume":"42","author":"DR Tashkin","year":"2002","unstructured":"Tashkin, D. R., Baldwin, G. C., Sarafian, T., Dubinett, S. & Roth, M. D. Respiratory and immunologic consequences of marijuana smoking. J. Clin. Pharmacol. 42, 71S\u201381S (2002).","journal-title":"J. Clin. Pharmacol."},{"key":"BFnrc1188_CR81","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/j.1360-0443.1996.tb02264.x","volume":"91","author":"IB Adams","year":"1996","unstructured":"Adams, I. B. & Martin, B. R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 91, 1585\u20131614 (1996).","journal-title":"Addiction"},{"key":"BFnrc1188_CR82","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen, F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42, 327\u2013360 (2003).","journal-title":"Clin. Pharmacokinet."},{"key":"BFnrc1188_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/faat.1996.0048","volume":"30","author":"PC Chan","year":"1996","unstructured":"Chan, P. C., Sills, R. C., Braun, A. G., Haseman, J. K. & Bucher, J. R. Toxicity and carcinogenicity of \u03949\u2013tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fund. Appl. Toxicol. 30, 109\u2013117 (1996).","journal-title":"Fund. Appl. Toxicol."},{"key":"BFnrc1188_CR84","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","volume":"3","author":"TP Malan","year":"2003","unstructured":"Malan, T. P. et al. CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr. Opin. Pharmacol. 3, 62\u201367 (2003).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrc1188_CR85","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0006-2952(00)00492-5","volume":"60","author":"SO Jacobsson","year":"2000","unstructured":"Jacobsson, S. O., Rongard, E., Stridh, M., Tiger, G. & Fowler, C. J. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem. Pharmacol. 60, 1807\u20131813 (2000).","journal-title":"Biochem. Pharmacol."},{"key":"BFnrc1188_CR86","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","volume":"42","author":"R Mechoulam","year":"2002","unstructured":"Mechoulam, R., Parker, L. A. & Gallily, R. Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol. 42, 11S\u201319S (2002).","journal-title":"J. Clin. Pharmacol."},{"key":"BFnrc1188_CR87","first-page":"494","volume":"1","author":"E Pop","year":"2000","unstructured":"Pop, E. Dexanabinol Pharmos. Curr. Opin. Investig. Drugs 1, 494\u2013503 (2000).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"BFnrc1188_CR88","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0006-2952(01)00700-6","volume":"62","author":"LD Recht","year":"2001","unstructured":"Recht, L. D. et al. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid. Biochem. Pharmacol. 62, 755\u2013763 (2001).","journal-title":"Biochem. Pharmacol."},{"key":"BFnrc1188_CR89","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1021\/jm970126f","volume":"40","author":"MH Rhee","year":"1997","unstructured":"Rhee, M. H. et al. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J. Med. Chem. 40, 3228\u20133233 (1997).","journal-title":"J. Med. Chem."},{"key":"BFnrc1188_CR90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nm0602-547","volume":"8","author":"M Bifulco","year":"2002","unstructured":"Bifulco, M. & Di Marzo, V. Targeting the endocannabinoid system in cancer therapy: a call for further research. Nature Med. 8, 547\u2013550 (2002). An enjoyable commentary about the possible antitumour action of the endogenous cannabinoid system.","journal-title":"Nature Med."},{"key":"BFnrc1188_CR91","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1080\/1042819031000103917","volume":"44","author":"R Gallily","year":"2003","unstructured":"Gallily, R. et al. \u03b3-Irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL\u201360 myeloblastic leukemia cells. Leukemia Lymphoma 44, 1767\u20131773 (2003).","journal-title":"Leukemia Lymphoma"},{"key":"BFnrc1188_CR92","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/bj20021878","volume":"371","author":"NS Radin","year":"2003","unstructured":"Radin, N. S. Killing tumours by ceramide-induced apoptosis: a critique of available drugs. Biochem. J. 371, 243\u2013256 (2003).","journal-title":"Biochem. J."},{"key":"BFnrc1188_CR93","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/jnci\/92.23.1897","volume":"92","author":"BJ Maurer","year":"2000","unstructured":"Maurer, B. J., Melton, L., Billups, C., Cabot, M. C. & Reynolds, C. P. Synergistic cytotoxicity in solid tumor cell lines between N-(4- hydroxyphenyl)retinamide and modulators of ceramide metabolism. J. Natl Cancer Inst. 92, 1897\u20131909 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc1188_CR94","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1101\/gad.891601","volume":"15","author":"EA Maher","year":"2001","unstructured":"Maher, E. A. et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 15, 1311\u20131333 (2001).","journal-title":"Genes Dev."},{"key":"BFnrc1188_CR95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1535-6108(02)00040-5","volume":"1","author":"DN Louis","year":"2002","unstructured":"Louis, D. N., Pomeroy, S. L. & Cairncross, J. G. Focus on central nervous system neoplasia. Cancer Cell 1, 125\u2013128 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc1188_CR96","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","volume":"100","author":"RJ McKallip","year":"2002","unstructured":"McKallip, R. J. et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100, 627\u2013634 (2002).","journal-title":"Blood"},{"key":"BFnrc1188_CR97","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/0006-2952(78)90553-1","volume":"27","author":"MJ Mon","year":"1978","unstructured":"Mon, M. J., Jansing, R. L., Doggett, S., Stein, J. L. & Stein, G. S. Influence of \u03949\u2013tetrahydrocannabinol on cell proliferation and macromolecular biosynthesis in human cells. Biochem. Pharmacol. 27, 1759\u20131765 (1978).","journal-title":"Biochem. Pharmacol."},{"key":"BFnrc1188_CR98","first-page":"133","volume":"44","author":"RD Blevins","year":"1980","unstructured":"Blevins, R. D. & Smith, D. P. Effects of \u0394-9-tetrahydrocannabinol on cultured HeLa cell growth and development. Growth 44, 133\u2013138 (1980).","journal-title":"Growth"},{"key":"BFnrc1188_CR99","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0014-5793(99)01073-X","volume":"458","author":"L Ruiz","year":"1999","unstructured":"Ruiz, L., Miguel, A. & Diaz-Laviada, I. \u03949\u2013tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett. 458, 400\u2013404 (1999).","journal-title":"FEBS Lett."},{"key":"BFnrc1188_CR100","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"W Devane","year":"1992","unstructured":"Devane, W. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946\u20131949 (1992). The discovery of anandamide, the first endogenous ligand of cannabinoid receptors.","journal-title":"Science"},{"key":"BFnrc1188_CR101","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam, R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83\u201390 (1995).","journal-title":"Biochem. Pharmacol."},{"key":"BFnrc1188_CR102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T Sugiura","year":"1995","unstructured":"Sugiura, T. et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89\u201397 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrc1188_CR103","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. & Bonner, T. I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561\u2013564 (1990). The molecular characterization of CB 1 \u2014 the first specific cannabinoid receptor.","journal-title":"Nature"},{"key":"BFnrc1188_CR104","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro, S., Thomas, K. L. & Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61\u201365 (1993).","journal-title":"Nature"},{"key":"BFnrc1188_CR105","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V Di Marzo","year":"1994","unstructured":"Di Marzo, V. et al. Formation and inactivation of endogenous cannabinoid anandamide. Nature 372, 686\u2013691 (1994). The discovery of the currently accepted molecular mechanism of endocannabinoid biosynthesis.","journal-title":"Nature"},{"key":"BFnrc1188_CR106","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/42015","volume":"388","author":"N Stella","year":"1997","unstructured":"Stella, N., Schweitzer, P. & Piomelli, D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773\u2013778 (1997).","journal-title":"Nature"},{"key":"BFnrc1188_CR107","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","volume":"277","author":"M Beltramo","year":"1997","unstructured":"Beltramo, M. et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094\u20131097 (1997).","journal-title":"Science"},{"key":"BFnrc1188_CR108","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt, B. F. et al. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83\u201387 (1996).","journal-title":"Nature"},{"key":"BFnrc1188_CR109","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0165-6147(00)01482-6","volume":"21","author":"D Piomelli","year":"2000","unstructured":"Piomelli, D., Giuffrida, A., Calignano, A. & Rodr\u00edguez de Fonseca, F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci. 21, 218\u2013224 (2000).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrc1188_CR110","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/35069076","volume":"410","author":"RI Wilson","year":"2001","unstructured":"Wilson, R. I. & Nicoll, R. A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410, 588\u2013592 (2001).","journal-title":"Nature"},{"key":"BFnrc1188_CR111","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0165-6147(00)01805-8","volume":"22","author":"E Schlicker","year":"2001","unstructured":"Schlicker, E. & Kathmann, M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22, 565\u2013572 (2001).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrc1188_CR112","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1523\/JNEUROSCI.22-09-03326.2002","volume":"22","author":"R Maldonado","year":"2002","unstructured":"Maldonado, R. & Rodriguez de Fonseca, F. Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci. 22, 3326\u20133331 (2002).","journal-title":"J. Neurosci."},{"key":"BFnrc1188_CR113","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/02791072.1998.10399689","volume":"30","author":"SR Calhoun","year":"1998","unstructured":"Calhoun, S. R., Galloway, G. P. & Smith, D. E. Abuse potential of dronabinol (Marinol). J. Psychoactive Drugs 30, 187\u2013196 (1998).","journal-title":"J. Psychoactive Drugs"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc1188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1188","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc1188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:26:09Z","timestamp":1684455969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc1188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":113,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["BFnrc1188"],"URL":"https:\/\/doi.org\/10.1038\/nrc1188","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}